If you have any questions, please e-mail:

For additional information and media contacts:

Börje Haraldsson, CEO
+46 (0)70 267 9544 

Oncorena respects your interest in how your personal data is processed. We hereby want to inform you on how we will use your personal data and what rights you have.

Please read more in the Privacy Policy.

Quick Facts

Are you or do you have possible candidates for our clinical trials?

We are looking for patients who suffer from metastatic renal cancer and would like to participate in a clinical trial to test a new potential treatment. The objective of the study is to evaluate the safety, tolerability, and anti-tumor efficacy of orellanine treatment in patients with Metastatic Clear-Cell or Papillary Renal Cell Carcinoma. Find out more about the trial and check your or your candidate’s eligibility here:

Read more
Alternate Text